Zertifizierungsrichtlinien für QST-Labore

[1]  R. Treede,et al.  Habituation and short‐term repeatability of thermal testing in healthy human subjects and patients with chronic non‐neuropathic pain , 2009, European journal of pain.

[2]  R. Baron,et al.  Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: Comparison of different diagnostic modalities , 2009, European journal of pain.

[3]  H. Krämer,et al.  Warm and cold complex regional pain syndromes , 2009, Neurology.

[4]  Klaus Züchner,et al.  Effect of thermode application pressure on thermal threshold detection , 2008, Muscle & nerve.

[5]  R. Treede,et al.  Detection of a characteristic painful neuropathy in Fabry disease: a pilot study. , 2008, Pain medicine.

[6]  G. Wasner,et al.  Determinants of thermal pain thresholds in normal subjects , 2008, Clinical Neurophysiology.

[7]  P. M. Rossini,et al.  Recommendations for the clinical use of somatosensory-evoked potentials , 2008, Clinical Neurophysiology.

[8]  S. Azad,et al.  Interaction of Hyperalgesia and Sensory Loss in Complex Regional Pain Syndrome Type I (CRPS I) , 2008, PloS one.

[9]  R. Treede,et al.  Pseudoradicular and radicular low-back pain – A disease continuum rather than different entities? Answers from quantitative sensory testing , 2008, PAIN®.

[10]  U. Schlegel,et al.  [Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options]. , 2008, Schmerz.

[11]  C. Maier,et al.  Schmerzhaftes Hyperexzitabilitätssyndrom unter Oxaliplatin-haltiger Chemotherapie , 2007, Der Schmerz.

[12]  M. Dieterich,et al.  200 TEST/RETEST‐ AND INTEROBSERVER‐RELIABILITIY IN QUANTITATIVE SENSORY TESTING ACCORDING TO THE PROTOCOL OF THE GERMAN NETWORK ON NEUROPATHIC PAIN (DFNS) , 2007 .

[13]  P. M. Lang,et al.  Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease , 2006, Pain.

[14]  G. Cruccu,et al.  Assessment of neuropathic pain , 2006, Neurological Sciences.

[15]  F. Birklein,et al.  Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values , 2006, PAIN.

[16]  G. Cruccu,et al.  Pathophysiological mechanisms of neuropathic pain , 2006, Neurological Sciences.

[17]  R. Treede,et al.  Quantitative sensory testing: a comprehensive protocol for clinical trials , 2006, European journal of pain.

[18]  D. Cros,et al.  Technology literature review: Quantitative sensory testing , 2004, Muscle & nerve.

[19]  B. Arnett Arnold-Chiari malformation. , 2003, Archives of neurology.

[20]  R. D. de Haan,et al.  The reliability of assessment of vibration sense , 2003, Acta neurologica Scandinavica.

[21]  J C Arezzo,et al.  Quantitative sensory testing , 2003, Neurology.

[22]  R. Baron,et al.  Translation of symptoms and signs into mechanisms in neuropathic pain , 2003, Pain.

[23]  R. Freeman,et al.  Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy , 2003, Neurology.

[24]  P. Hansson Neuropathic pain: clinical characteristics and diagnostic workup , 2002, European journal of pain.

[25]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[26]  David Yarnitsky,et al.  Heat pain thresholds: normative data and repeatability , 1995, Pain.

[27]  David Yarnitsky,et al.  Quantitative Sensory Testing , 1992, Diabetes Care.